| | |||||
| Ebola | |||||
| NEWS | |||||
| Department of the Army, the Surgeon General-Sponsored Assay Supports First-Ever FDA ... 20, 2019, pharmaceutical company Merck Sharp & Dohme received FDA-approval of their Ebola vaccine, Ervebo, known in the U.S. as "V920.
| |||||
| Global health bright spots 2019 In 2019, substantial gains were made in responding to the world's second largest Ebola epidemic on record in the Democratic Republic of the Congo.
| |||||
| Legislation Curbing Drug Prices Was Supposed To Be One Of Few Bipartisan Wins This Year. Yet ... In other pharmaceutical news: doctors' financial links to pharma, Medicaid approval for a sickle cell treatment, the Ebola vaccine, and electronic ...
| |||||
| From ICASA to First Female Neurosurgeon; How Rwanda Sent Off 2019 In August this year, Rwanda faced yet another big test, when its neighbor – Democratic Republic of Congo (DRC) was hit by deadly Ebola outbreak.
| |||||
| Close to 1400 dependants of Rwandan militia repatriate, await reintegration ... Center, Mugabe said, these people are given requisite medical attention and care, and so far, "there has not been any case of Ebola detected.".
| |||||
| Analyzing Future Direction of NewLink Genetics Corporation (NLNK): Next Earning Report on 02 ... ... five trading sessions. Press Release reported on 12/20/19 that NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO(R)) ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar